威高血净
(603014)
| 流通市值：16.47亿 | | | 总市值：174.75亿 |
| 流通股本：3936.73万 | | | 总股本：4.18亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,736,052,670.24 | 1,764,680,364.12 | 895,991,790.32 | 3,604,017,778.24 |
| 营业收入 | 2,736,052,670.24 | 1,764,680,364.12 | 895,991,790.32 | 3,604,017,778.24 |
| 二、营业总成本 | 2,345,783,937.85 | 1,517,719,836.84 | 755,825,945.1 | 3,089,995,614 |
| 营业成本 | 1,622,620,708.78 | 1,039,385,001.73 | 529,345,522.03 | 2,079,825,544.72 |
| 税金及附加 | 38,627,463.44 | 28,857,798.17 | 10,753,372.85 | 50,342,276.86 |
| 销售费用 | 446,047,832.47 | 292,882,038.34 | 141,766,315.43 | 630,390,685.99 |
| 管理费用 | 132,273,878.93 | 87,887,839.91 | 44,245,944.02 | 170,669,726.84 |
| 研发费用 | 105,705,786.32 | 70,178,671.88 | 30,441,281.37 | 164,697,342.22 |
| 财务费用 | 508,267.91 | -1,471,513.19 | -726,490.6 | -5,929,962.63 |
| 其中:利息费用 | 283,020.98 | 233,422.09 | 118,796.58 | 601,103.86 |
| 其中:利息收入 | 1,593,221.93 | 1,771,084.14 | 844,697.62 | 4,341,891.1 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 998,835.62 | 902,054.6 | 650,801.37 | 223,382.45 |
| 加:投资收益 | 33,720,777.75 | 20,167,729.45 | 8,960,162.76 | 36,223,385.35 |
| 资产处置收益 | 24,614.94 | 21,568.75 | 21,652.91 | 202,826.74 |
| 资产减值损失(新) | -7,772,260.54 | -6,256,028.51 | -5,508,161.84 | -8,309,733.72 |
| 信用减值损失(新) | -22,782,858.05 | -3,985,682.74 | -15,105,531.15 | -38,707,199.7 |
| 其他收益 | 17,076,905.61 | 9,840,937.96 | 5,464,969.79 | 48,740,333.97 |
| 四、营业利润 | 411,534,747.72 | 267,651,106.79 | 134,649,739.06 | 552,395,159.33 |
| 加:营业外收入 | 583,025.99 | 372,013.92 | 112,111.4 | 1,334,673.26 |
| 减:营业外支出 | 5,712,368.48 | 3,860,638.33 | 535,210.44 | 8,047,180.99 |
| 五、利润总额 | 406,405,405.23 | 264,162,482.38 | 134,226,640.02 | 545,682,651.6 |
| 减:所得税费用 | 65,627,345.88 | 43,925,131.51 | 21,869,588.55 | 96,313,784.92 |
| 六、净利润 | 340,778,059.35 | 220,237,350.87 | 112,357,051.47 | 449,368,866.68 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 340,778,059.35 | 220,237,350.87 | 112,357,051.47 | 449,368,866.68 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 340,778,059.35 | 220,237,350.87 | 112,357,051.47 | 449,368,866.68 |
| 扣除非经常损益后的净利润 | 333,221,997.86 | 214,612,844.34 | 110,038,251.47 | 439,166,620.09 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.85 | 0.58 | 0.31 | 1.21 |
| (二)稀释每股收益 | 0.85 | 0.58 | 0.31 | 1.21 |
| 八、其他综合收益 | -59,253.35 | -154,455.08 | -173,787.38 | 138,876.73 |
| 归属于母公司股东的其他综合收益 | -59,253.35 | -154,455.08 | -173,787.38 | 138,876.73 |
| 九、综合收益总额 | 340,718,806 | 220,082,895.79 | 112,183,264.09 | 449,507,743.41 |
| 归属于母公司股东的综合收益总额 | 340,718,806 | 220,082,895.79 | 112,183,264.09 | 449,507,743.41 |
| 公告日期 | 2025-10-31 | 2025-08-28 | 2025-05-16 | 2025-02-19 |
| 审计意见(境内) | | | | 标准无保留意见 |